RESUMEN

This paper attempts to evaluate the effects of in-vehicle warning information on drivers' decelerating and accelerating behavior when approaching an intersection near an arch-shaped bridge, where traffic accidents have often occurred due to poor visibility. The warning information was provided with images and/or voice, triggered by the actual presence of a stopped vehicle at the downhill road section of the intersection. An on-site driving experiment was conducted on a national highway in Hiroshima City, Japan, by involving 14 university students, and it was demonstrated that dynamic information seems more effective for drivers to avoid dangerous driving situations than static information. It was also found that having only the voice-based warning information may be as effective as having both the voice and image warning information.

Asunto(s)

Aceleración , Conducción de Automóvil , Automóviles , Sistemas de Computación , Conductas Relacionadas con la Salud , Seguridad , Atención , Intervalos de Confianza , Seguridad de Equipos , Femenino , Humanos , Japón , Masculino , Percepción , Administración de la Seguridad , Estadística como Asunto

RESUMEN

Adlayers consisting of two components selected from the group of cobalt(II) tetraphenylporphyrin (CoTPP), copper(II) tetraphenylporphyrin (CuTPP), and zinc(II) tetraphenylporphyrin (ZnTPP) were prepared by immersing Au(111) substrate in a benzene solution containing those molecules. The bimolecular adlayers thus prepared were investigated in 0.1 M HClO4 by electrochemical scanning tunneling microscopy (EC-STM). The mixed adlayers consisting of CoTPP and CuTPP formed structurally ordered but compositionally disordered arrays on Au(111). The ratio of CoTPP to CuTPP molecules in the mixed adlayer was proportional to the ratio of CoTPP to CuTPP molecules in the solution phase. Accordingly, the composition of CoTPP and CuTPP in the adlayer on the Au(111) surface was independent of absolute concentrations of these species in the solution and immersion time. In contrast, the structural feature of the mixed adlayer consisting of CoTPP and ZnTPP was similar to that of the mixed adlayer of CoTPP and CuTPP when these adlayers were prepared in solutions containing those mixtures at a total concentration of 100 microM, whereas when the total concentration was lower, adsorption was site-selective depending on the coordinated metal ion. This finding indicates that the herringbone structure of reconstructed Au(111) served as a template for the bimolecular assembly of CoTPP and ZnTPP. The characteristic phase separation of CoTPP and ZnTPP molecules assisted by reconstructed Au(111) surface can be controlled by the subtle balance between kinetics and thermodynamics.

RESUMEN

Irinotecan hydrochloride (CPT-11) is an effective anticancer drug, and its metabolic pathway has been well studied. Nevertheless, in human hepatocellular carcinoma (HCC), its cytotoxicity is less well studied and the determination of its chemosensitivity is unclear. We, therefore, examined chemosensitivities of HCC cell lines for CPT-11 and SN-38, and mRNA expressions of several molecules in their metabolic pathway. Three markers were found to correlate well with chemosensitivity: breast cancer resistance protein (BCRP), cytochrome P450 (CYP) 3A4 and uridine diphosphate-glucuronosyl transferase (UGT) 1A1. Next, CYP3A4/UGT1A1/BCRP inhibitor naringenin and BCRP inhibitor elacridar were tested for enhancement of their chemosensitivity. Both of naringenin and elacridar separately enhanced the sensitivity for CPT-11 and SN-38 in KYN-2 cells abundantly expressing BCRP, CYP3A4/5 and UGT1A1, but not in KYN-1 cells expressing lower levels. However, naringenin had little effect on the sensitivity in JHH-4 and HLE cells with higher CYP3A4/5 and lower UGT1A1 and BCRP expression. On the other hand, naringenin and elacridar significantly increased the chemosensitivity for CPT-11 and SN-38 in the KYN-1-derived cells artificially overexpressing BCRP. Furthermore, flow cytometric analysis showed that naringenin raised intracellular accumulation of CPT-11 as well as elacridar. Those results suggest that BCRP is one of the chemosensitivity determinants of CPT-11 in HCC cells and its inhibition might be critical for cells expressing abundant BCRP.

Asunto(s)

Transportadoras de Casetes de Unión a ATP/metabolismo , Antineoplásicos Fitogénicos/farmacología , Camptotecina/análogos & derivados , Carcinoma Hepatocelular/metabolismo , Neoplasias Hepáticas/metabolismo , Proteínas de Neoplasias/metabolismo , Transportador de Casetes de Unión a ATP, Subfamilia G, Miembro 2 , Transportadoras de Casetes de Unión a ATP/antagonistas & inhibidores , Transportadoras de Casetes de Unión a ATP/genética , Acridinas/farmacología , Antineoplásicos Fitogénicos/metabolismo , Camptotecina/metabolismo , Camptotecina/farmacología , Carcinoma Hepatocelular/enzimología , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/patología , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Citocromo P-450 CYP3A , Inhibidores Enzimáticos del Citocromo P-450 , Sistema Enzimático del Citocromo P-450/metabolismo , Relación Dosis-Respuesta a Droga , Resistencia a Antineoplásicos/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Flavanonas/farmacología , Regulación Neoplásica de la Expresión Génica , Glucuronosiltransferasa/antagonistas & inhibidores , Glucuronosiltransferasa/metabolismo , Humanos , Concentración 50 Inhibidora , Irinotecán , Neoplasias Hepáticas/enzimología , Neoplasias Hepáticas/patología , Proteínas de Neoplasias/antagonistas & inhibidores , Proteínas de Neoplasias/genética , ARN Mensajero/metabolismo , Tetrahidroisoquinolinas/farmacología , Transfección

RESUMEN

Two-component adlayers consisting of cobalt(II) phthalocyanine (CoPc) and a metalloporphyrin such as 5,10,15,20-tetraphenyl-21H,23H-porphine copper(II) (CuTPP), 2,3,7,8,12,13,17,18-octaethyl-21H,23H-porphine copper(II) (CuOEP), or 5,10,15,20-tetraphenyl-21H,23H-porphine cobalt(II) (CoTPP) were prepared by immersing either an Au(111) or Au(100) substrate in a benzene solution containing those molecules. The mixed adlayers thus prepared were investigated in 0.1 M HClO4 by cyclic voltammetry (CV) and in situ scanning tunneling microscopy (STM). The composition of the mixed adlayer consisting of CoPc and CuTPP molecules was found to vary with immersion time. CoPc molecules displaced CuTPP molecules during the modification process with increasing immersion time, and the CuTPP molecules were completely displaced by CoPc molecules in the mixed solution after a prolonged modification time, during which the underlying Au(100) substrate underwent phase transition from the reconstructed (hex) lattice to the unreconstructed (1 x 1) lattice. The two-component adlayer of CoPc and CuTPP was found to form a supramolecular adlayer with the constituent molecules arranged alternately on Au(100)-(hex). The striped structure was stable on Au(100)-(hex) at or near the open circuit potential (OCP), whereas the mixed adlayer was disordered on Au(100)-(1 x 1) at potentials more positive than OCP, where the phase transition of the arrangement of underlying Au atoms (i.e., the lifting of reconstruction) was induced electrochemically. A similar two-component supramolecular adlayer consisting of CoPc and CuTPP was formed on Au(111). A highly ordered, compositionally disordered adlayer of CoTPP and CuTPP was formed on Au(100)-(hex), suggesting that the adlayer structure is independent of the coordinated central metal ion for the formation of supramolecular nanostructures composed of those molecules. A supramolecular organization of CoPc and CuOEP was also found on Au(111). The surface mobility and the molecular reorganization of CoPc and CuOEP on Au(111) were tuned by modulation of the electrode potential. It is concluded that molecular assemblies of the two-component structure consisting of phthalocyanine and porphyrin were controlled not only by the crystallographic orientation of Au but also by the modulation of electrochemical potential.

RESUMEN

OBJECTIVE: To investigate the effects of mild to moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of landiolol hydrochloride, a new ultra-short-acting beta1-adrenergic antagonist. METHODS: Six patients with hepatic impairment and six healthy volunteers were enrolled in the open-label, parallel-group study. Landiolol hydrochloride was given intravenously with a 1-minute loading infusion of 0.06 mg/kg/min, followed by a 60-minute infusion of 0.02 mg/kg/min using an automated infusion pump. Venous blood was drawn just before (predose) and 1, 2, 5, 15, 30 and 61 minutes after beginning the continuous intravenous infusion (during infusion); 2, 5, 10 and 30 minutes and 1, 4 and 8 hours after the end of the infusion (after infusion); and 24 hours after beginning the infusion (next day). Urine samples were collected up to 24 hours after beginning the infusion. Before subjects were discharged, an indocyanine green elimination test, clinical laboratory testing, physical examination and recording of ECGs and vital signs were performed. RESULTS: The geometric mean maximum plasma concentration and area under the concentration-time curve values for the patients with hepatic impairment were 42% and 44% higher, respectively, than those observed for the healthy volunteers, indicating that hepatic impairment affected the disposition of landiolol hydrochloride. There were no significant changes in the elimination half-life of the drug. There were no clinically significant differences between the two groups in terms of reductions in heart rate or blood pressure. CONCLUSION: The pharmacokinetic and pharmacodynamic characteristics of this ultra-short-acting beta1-blocker were maintained even in the patients with hepatic impairment. Although we did not observe any drug-related adverse events in these patients, hypotension or bradycardia should be considered, necessitating continuous monitoring of both heart rate and BP in patients with hepatic impairment who receive landiolol hydrochloride.

Asunto(s)

Antagonistas Adrenérgicos beta , Frecuencia Cardíaca/efectos de los fármacos , Hepatopatías/metabolismo , Morfolinas , Receptores Adrenérgicos beta 1/metabolismo , Urea/análogos & derivados , Antagonistas Adrenérgicos beta/administración & dosificación , Antagonistas Adrenérgicos beta/farmacocinética , Antagonistas Adrenérgicos beta/farmacología , Anciano , Femenino , Humanos , Infusiones Intravenosas , Hepatopatías/fisiopatología , Masculino , Tasa de Depuración Metabólica , Persona de Mediana Edad , Morfolinas/administración & dosificación , Morfolinas/farmacocinética , Morfolinas/farmacología , Urea/administración & dosificación , Urea/farmacocinética , Urea/farmacología

RESUMEN

Adlayers of 15-crown-5-ether-substituted cobalt(II) phthalocyanine (CoCRPc) were prepared by immersion of either Au(111) or Au(100) substrate into benzene-ethanol (9:1 v/v) mixed solutions containing CoCRPc. In situ STM imaging was carried out after transferring the CoCRPc-modified Au crystals into aqueous HClO(4) solution. The packing arrangement of the CoCRPc array on Au(111) was determined to be p(8 x 4 radical 3R - 30 degrees ), and the internal structure was clearly observed by high-resolution STM. Two adlayer structures of CoCRPc, (8 x 9) and (4 radical 5 x 4 radical 5)R26.7 degrees, were found on the Au(100)-(1 x 1) terrace. In the presence of 1 mM Ca(2+), two Ca(2+) ions were trapped in two diagonally located 15-crown-5-ether moieties of each CoCRPc molecule on Au(111), whereas encapsulation of Ca(2+) ions was not seen in the CoCRPc arrays on the Au(100)-(1 x 1) surface. The present study demonstrates that the relationship between crown moieties of CRPc and the underlying Au lattice is important in the trapping of Ca(2+) ions in crown rings.

RESUMEN

Molecules of copper(II) and cobalt(II) 5,10,15,20-tetraphenyl-21H,23H-porphine (CuTPP and CoTPP) and cobalt(II) phthalocyanine (CoPc) are spontaneously adsorbed onto reconstructed Au(100) substrate from a benzene solution containing each individual complex. In situ scanning tunneling microscopy (STM) was used to examine the real-space arrangement and the internal molecular structure of each of the individual molecules in 0.1 M HClO4 under potential control. The adsorption of CuTPP and CoTPP produced the same highly ordered square array with an intermolecular spacing of 1.44 nm on a reconstructed Au(100) surface. These molecular superlattices and the underlying reconstructed Au(100) predominated between 0 and 0.9 V, but lifting of the reconstructed Au(100) surface and elimination of the ordered adlayers occurred at more positive potentials. Molecular resolution STM revealed propeller-shaped admolecule with its center imaged as a protrusion for Co(II) and a depression for Cu(II). In contrast, the spontaneous adsorption of CoPc molecules resulted in a rapid phase transition from the reconstructed Au(100) surface to the (1 x 1) phase, coupled with the production of locally ordered, square-shaped arrays with an intermolecular distance of 1.65 nm. This molecular adlayer and the Au(100)-(1 x 1) remained unchanged when the potential was modulated between 0 and 1.0 V. These results indicate that the subtle variation in the molecular structure of adsorbate influenced not only its spatial arrangement but also the structure of the underlying Au(100) substrate.

RESUMEN

By immersing Au substrate into a benzene solution containing both cobalt(II) phthalocyanine (CoPc) and copper(II) tetraphenyl-21H,23H-porphine (CuTPP), a two-dimensional alternate bimolecular structure was formed on the reconstructed Au(100)-(hex) surface.

RESUMEN

High-resolution scanning tunneling microscopy has revealed that, of the four crown-ether moieties of 15-crown-5-ed phthalocyanine array on Au(111) surface, only two crown-ether voids at diagonal positions, where the void centers and hollows surrounded by three gold atoms match exactly, trap two Ca2+ ions.